Abstract

Complex formation between coagulation factor VIII (FVIII) and von Willebrand factor (VWF) is of critical importance to protect FVIII from rapid in vivo clearance and degradation. We have now employed a chemical footprinting approach to identify regions on VWF involved in FVIII binding. To this end, lysine amino acid residues of VWF were chemically modified in the presence of FVIII or activated FVIII, which does not bind VWF. Nano-LC-MS analysis showed that the lysine residues of almost all identified VWF peptides were not differentially modified upon incubation of VWF with FVIII or activated FVIII. However, Lys-773 of peptide Ser-766-Leu-774 was protected from chemical modification in the presence of FVIII. In addition, peptide Ser-764-Arg-782, which comprises the first 19 amino acid residues of mature VWF, showed a differential modification of both Lys-773 and the α-amino group of Ser-764. To verify the role of Lys-773 and the N-terminal Ser-764 in FVIII binding, we employed VWF variants in which either Lys-773 or Ser-764 was replaced with Ala. Surface plasmon resonance analysis and competition studies revealed that VWF(K773A) exhibited reduced binding to FVIII and the FVIII light chain, which harbors the VWF-binding site. In contrast, VWF(S764A) revealed more effective binding to FVIII and the FVIII light chain compared with WT VWF. The results of our study show that the N terminus of VWF is critical for the interaction with FVIII and that Ser-764 and Lys-773 have opposite roles in the binding mechanism.

Highlights

  • Coagulation factor VIII (FVIII)2 and von Willebrand factor (VWF) play a critical but distinct role in the arrest of bleeding at Sanquin Research, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands

  • If FVIII protects a lysine of VWF from chemical modification, we would expect identified peptides including this lysine residue to exhibit enhanced incorporation of Tandem mass tag (TMT)-127

  • Most of the lysine-containing peptides did not display any change in TMT-127:TMT-126 ratio upon incubation of VWF with FVIII and FVIIIa (Fig. 1 and supplemental Tables S1 and S2)

Read more

Summary

Introduction

Coagulation factor VIII (FVIII)2 and von Willebrand factor (VWF) play a critical but distinct role in the arrest of bleeding at Sanquin Research, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands. Lysine amino acid residues of VWF were chemically modified in the presence of FVIII or activated FVIII, which does not bind VWF. Nano-LC-MS analysis showed that the lysine residues of almost all identified VWF peptides were not differentially modified upon incubation of VWF with FVIII or activated FVIII.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call